IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price on Aug 13, 2025

IGM Biosciences Revenue

IGM Biosciences had revenue of $143.62M in the quarter ending June 30, 2025, with 11,353.19% growth. This brings the company's revenue in the last twelve months to $145.05M, up 4,882.82% year-over-year. In the year 2024, IGM Biosciences had annual revenue of $2.68M with 25.77% growth.

Revenue (ttm)
$145.05M
Revenue Growth
+4,882.82%
P/S Ratio
n/a
Revenue / Employee
$9,065,625
Employees
149
Market Cap
n/a

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.68M549.00K25.77%
Dec 31, 20232.13M1.06M99.25%
Dec 31, 20221.07M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition